Pink Sheet Podcast: Clinical Trial Diversity, Off-Label Standard Of Care Issues, In-Person US FDA Adcomms

 
• By Derrick Gingery, Sarah Karlin-Smith, and Sue Sutter
Pink Sheet podcast
Will advisory committee meetings change upon their return to fully in-person sessions? • Source: Citeline/Shutterstock

More from Diversity & Inclusion

More from Clinical Trials